HES1 oscillations are required for cell cycle reentry in oestrogen receptor–positive breast cancer cells
Open Access
- 2 March 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (10)
Abstract
Long-term recurrence in breast cancer is driven by reactivation of dormant disseminated tumor cells (DTCs) and remains a major clinical challenge, particularly in estrogen receptor–positive (ER + ) tumors. This process is underpinned by regulation of the cell cycle machinery that controls quiescence maintenance and exit. HES1, a Notch pathway transcription factor, regulates key cell cycle genes and has been shown to demonstrate protein expression oscillations. Here, we sought to establish whether HES1 oscillations may regulate ER+ cancer cell quiescence and reactivation. To investigate this, we developed a fundamental in vitro model of cell cycle arrest and reentry based on reversible CDK4/6 inhibition (CDK4/6i) with palbociclib, compatible with quantitative single-cell live-imaging of a knock-in endogenous HES1 reporter. Consistent with earlier findings, HES1 exhibited ~24 h protein oscillations in cycling cells demonstrating a reproducible dip in protein expression prior to S-Phase. During CDK4/6i-mediated arrest, the ~24 h HES1 oscillation was lost, HES1 levels were maintained at a moderately higher level and HES1 exhibited smaller dips. Similar changes were observed in unperturbed, spontaneously quiescent cells. Following release from CDK4/6i and cell cycle reentry, these alterations were reversed and the characteristic G1/S HES1 dip was observed. Preventing this dip at the point of release, by inducibly sustaining HES1 with a Tet-On system, upregulated the cell cycle inhibitor p21, impeded cell cycle reentry and induced cell death. These findings suggest that manipulating HES1 dynamics could represent a promising therapeutic approach to prevent reactivation of dormant tumor cells.Keywords
Funding Information
- Cancer Research UK (DRCMDP-Nov22/100009)
- Wellcome Trust (224394/Z/21/Z)
- UKRI | Medical Research Council (P119489)
This publication has 71 references indexed in Scilit:
- Hes1 is required for contact inhibition of cell proliferation in 3T3-L1 preadipocytesGenes to Cells, 2011
- MicroRNA-9 Reveals Regional Diversity of Neural Progenitors along the Anterior-Posterior AxisDevelopmental Cell, 2011
- Hes-6, an inhibitor of Hes-1, is regulated by 17β-estradiol and promotes breast cancer cell proliferationBreast Cancer Research, 2009
- Testing for nested oscillationJournal of Neuroscience Methods, 2008
- Oscillations in Notch Signaling Regulate Maintenance of Neural ProgenitorsNeuron, 2008
- Hes1 Directly Controls Cell Proliferation through the Transcriptional Repression of p27Kip1Molecular and Cellular Biology, 2005
- HES-1 inhibits 17β-estradiol and heregulin-β1-mediated upregulation of E2F-1Oncogene, 2004
- Notch in mammary gland development and breast cancerSeminars in Cancer Biology, 2004
- Oscillatory Expression of Hes1, p53, and NF-κB Driven by Transcriptional Time DelaysCurrent Biology, 2003
- HES-1 Repression of Differentiation and Proliferation in PC12 Cells: Role for the Helix 3-Helix 4 Domain in Transcription RepressionMolecular and Cellular Biology, 2000